TerrAscend Corp. TRSSF TER appointed Ira Duarte to its board of directors. In addition, Duarte will serve as the chair of the audit committee of the board of directors.
Duarte is an accomplished senior finance professional with more than 25 years of experience in a variety of finance, accounting and auditing leadership roles. She currently serves as CFO of Veloxis Pharmaceuticals, Inc., a fully integrated specialty pharmaceutical company focused on the global development and commercialization of medications utilized by organ transplant patients. Prior to joining Veloxis, Duarte served as senior director of corporate finance for Chiesi USA, Inc. and director of accounting and financial planning for Cornerstone Therapeutics, Inc., where she was a core member of the team that guided the sale of Cornerstone Therapeutics, Inc. to Chiesi Farmaceutici S.p.A.
"I'm delighted to be joining TerrAscend's Board of Directors at this exciting moment in the company's evolution," stated Duarte. "The TerrAscend team has quickly established a reputation as a leading operator with strong growth potential. I look forward to supporting the audit committee on the financial reporting process and helping TerrAscend execute against its business strategy."
Jason Wild, executive chairman of TerrAscend, stated, "We are thrilled to add Ira to TerrAscend's board and look forward to leveraging her extensive corporate finance experience as we continue to execute on our financially disciplined growth strategy."
Get your daily dose of cannabis news on Benzinga Cannabis. Don’t miss out on any important developments in the industry.
- Massive Demand & Disruptive Potential – Boxabl has received interest for over 190,000 homes, positioning itself as a major disruptor in the housing market.
- Revolutionary Manufacturing Approach – Inspired by Henry Ford’s assembly line, Boxabl’s foldable tiny homes are designed for high-efficiency production, making homeownership more accessible.
- Affordable Investment Opportunity – With homes priced at $60,000, Boxabl is raising $1 billion to scale production, offering investors a chance to own a stake in its growth.
Related News
TerrAscend Reduces Outstanding Debt By $30M
New York Cannabis Control Board Approves Change Of Control Of Etain's Vertically Integrated License
TerrAscend Reports 3Q 2022 Financial Results: Net Revenue Up 36.4% YoY
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving—don’t get left behind!
Curious about what’s next for the industry and how to stay ahead in today’s competitive market?
Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.
Secure your spot now before prices go up—this is where the biggest deals and connections happen!
